Novartis Ag (NVS) Interest Expenses (2016 - 2025)
Historic Interest Expenses for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to -$304.0 million.
- Novartis Ag's Interest Expenses fell 1054.55% to -$304.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.1 billion, marking a year-over-year decrease of 1371.77%. This contributed to the annual value of -$1.1 billion for FY2025, which is 1371.77% down from last year.
- Per Novartis Ag's latest filing, its Interest Expenses stood at -$304.0 million for Q4 2025, which was down 1054.55% from -$281.0 million recorded in Q3 2025.
- In the past 5 years, Novartis Ag's Interest Expenses ranged from a high of -$200.0 million in Q1 2023 and a low of -$304.0 million during Q4 2025
- Its 5-year average for Interest Expenses is -$231.6 million, with a median of -$216.5 million in 2023.
- In the last 5 years, Novartis Ag's Interest Expenses surged by 1548.12% in 2021 and then plummeted by 2672.81% in 2024.
- Novartis Ag's Interest Expenses (Quarter) stood at -$206.0 million in 2021, then decreased by 0.49% to -$207.0 million in 2022, then dropped by 4.83% to -$217.0 million in 2023, then decreased by 26.73% to -$275.0 million in 2024, then decreased by 10.55% to -$304.0 million in 2025.
- Its last three reported values are -$304.0 million in Q4 2025, -$281.0 million for Q3 2025, and -$289.0 million during Q2 2025.